Elisabete Roldão is an Occupational Therapist since 1992 and is now finishing her PhD in Rehabilitation at Lisbon University. She is a professor of Health School of the Polytechnic Institute of Leiria, Portugal. She is the President of the Portuguese Association of Occupational Therapists, the representative of Portugal in the World Federation of Occupational Therapists and in the Council of Occupational Therapists for the European Countries. She is a member of the Technical Assessment Committee of the Occupational Therapy Area, and a member of the Working Group for the Analysis and Presentation of Proposals in the field of Physical Medicine and Rehabilitation in Ambulatory, created by the Central Administration of the Health System, IP. She is also a member of the Regional Council of Mental Health of ARSLVT. She is the Director of the Magazine APTO and the founding member of the International Interest Group of the Portuguese Association of Occupational Therapists.
Public Health in Disaster Management
Assist. Prof. Dragan Korolija-Marinic works as a consultant surgeon in a clinic specialized for tumours. Graduated at Zagreb Medical School in 1988, where he has also finished his Ph.D. in 2001. He has a list of original scientific papers with more than 300 citations of his work. In a period from 2012 to 2014 he was a CEO of Clinical Hospital in Zagreb, and then from 2014 to 2016 was appointed as Deputy Minister of Health in the Republic of Croatia. During that time he was responsible for the Hospital sector, where he has started various structural reforms and activities. These activities gave excellent results in 2015.
Pierre A. MORGON is CEO of MRGN Advisors and Regional Partner for Switzerland at Mérieux Développement. He is Chairman of the Board of Virometix, as well as Non-Executive Director to the Boards of Theradiag, of Eurocine Vaccines, and of Vaccitech. Pierre has over 30 years of experience in the global life science industry, especially with specialty care, vaccines and immunotherapy, at the helm of international operations, in C-level positions at global level in multinational corporations and as CEO of start-up companies. He is a lecturer in several MBA programs in world-class business schools and in life science conferences, and at the Mass Challenge biotechnology incubator in Switzerland. He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA. He is also an alumnus of INSEAD and IMD.
Dr Harinder Jaseja has worked as Professor in Physiology in G R Medical College, India and is presently consultant to Vellore EEG Center, Gwalior, India. He was ranked Second in Epilepsy Research in India in a 2013-published national neuroscience journal. He has discovered a novel target (pedunculopontine nucleus) for deep brain stimulation in intractable epilepsy and also designed an innovative approach to the selection of anterior thalamic nucleus deep brain stimulation parameters in intractable epilepsy that enhances its efficacy, success and expands its therapeutic spectrum. He has also published EEG-based novel guidelines for management of patients with cerebral palsy to improve their quality of life. He has published more than 75 international papers and is member of several editorial boards. In 2005, Dr Jaseja initiated a debate on the epileptogenic potential of Meditation. He has cautioned that meditation can under certain circumstances predispose its practitioner to epilepsy. This attracted wide criticism as meditation till 2005 was used as remedy for epilepsy even without knowing its mechanism of anti-epileptic property. Later, Dr Jaseja also published a paper on the anti-epileptic property of meditation at receptor level. Dr Jaseja has studied the effects of vagal nerve stimulation and has shown and claimed its efficacy in patients with CP, post which, CP has been include in the list of indications of VNS. Recently his work on VNS (Jaseja, H., "Vagal Nerve Stimulation Technique: Enhancing Its Efficacy and Acceptability by Augmentation with Auto Activation and Deactivation Mode of Operation," Medical Hypotheses, vol. 63, Issue 1, 2004, pp. 76-79) has been cited in Patent grant no. 2018-09-25 US10080895B2 Grant to Cyberonics Inc. Interestingly, he has shown that the Indian traditional application of Shoe-smell in Epilepsy has a sound scientific basis. In a small study, shoe smell was reported to posses beneficial effect (reduction in duration and severity) during an epileptic attack.